Central Garden & Pet Company Earnings Calls
| Release date | Nov 24, 2025 |
| EPS estimate | -$0.200 |
| EPS actual | - |
| Revenue estimate | 657.86M |
| Revenue actual | - |
| Expected change | +/- 2.81% |
| Release date | Aug 06, 2025 |
| EPS estimate | $1.34 |
| EPS actual | $1.56 |
| EPS Surprise | 16.42% |
| Revenue estimate | 657.86M |
| Revenue actual | 960.913M |
| Revenue Surprise | 46.07% |
| Release date | May 07, 2025 |
| EPS estimate | $0.94 |
| EPS actual | $1.04 |
| EPS Surprise | 10.64% |
| Revenue estimate | 876.36M |
| Revenue actual | 833.537M |
| Revenue Surprise | -4.89% |
| Release date | Feb 05, 2025 |
| EPS estimate | -$0.0300 |
| EPS actual | $0.210 |
| EPS Surprise | 800.00% |
| Revenue estimate | 906.02M |
| Revenue actual | 656.436M |
| Revenue Surprise | -27.55% |
Last 4 Quarters for Central Garden & Pet Company
Below you can see how CENT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 05, 2025 |
| Price on release | $37.07 |
| EPS estimate | -$0.0300 |
| EPS actual | $0.210 |
| EPS surprise | 800.00% |
| Date | Price |
|---|---|
| Jan 30, 2025 | $36.82 |
| Jan 31, 2025 | $36.49 |
| Feb 03, 2025 | $36.31 |
| Feb 04, 2025 | $36.80 |
| Feb 05, 2025 | $37.07 |
| Feb 06, 2025 | $40.16 |
| Feb 07, 2025 | $38.50 |
| Feb 10, 2025 | $38.45 |
| Feb 11, 2025 | $39.35 |
| 4 days before | 0.679% |
| 4 days after | 6.15% |
| On release day | 8.34% |
| Change in period | 6.87% |
| Release date | May 07, 2025 |
| Price on release | $34.45 |
| EPS estimate | $0.94 |
| EPS actual | $1.04 |
| EPS surprise | 10.64% |
| Date | Price |
|---|---|
| May 01, 2025 | $33.91 |
| May 02, 2025 | $34.60 |
| May 05, 2025 | $35.13 |
| May 06, 2025 | $34.55 |
| May 07, 2025 | $34.45 |
| May 08, 2025 | $34.59 |
| May 09, 2025 | $34.79 |
| May 12, 2025 | $36.05 |
| May 13, 2025 | $36.46 |
| 4 days before | 1.59% |
| 4 days after | 5.83% |
| On release day | 0.406% |
| Change in period | 7.52% |
| Release date | Aug 06, 2025 |
| Price on release | $39.41 |
| EPS estimate | $1.34 |
| EPS actual | $1.56 |
| EPS surprise | 16.42% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $39.02 |
| Aug 01, 2025 | $38.91 |
| Aug 04, 2025 | $39.53 |
| Aug 05, 2025 | $39.62 |
| Aug 06, 2025 | $39.41 |
| Aug 07, 2025 | $35.09 |
| Aug 08, 2025 | $34.09 |
| Aug 11, 2025 | $33.68 |
| Aug 12, 2025 | $35.24 |
| 4 days before | 1.00% |
| 4 days after | -10.58% |
| On release day | -10.97% |
| Change in period | -9.69% |
| Release date | Nov 24, 2025 |
| Price on release | - |
| EPS estimate | -$0.200 |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $31.59 |
| Nov 12, 2025 | $31.73 |
| Nov 13, 2025 | $31.94 |
| Nov 14, 2025 | $31.69 |
| Nov 17, 2025 | $31.04 |
Central Garden & Pet Company Earnings Call Transcript Summary of Q2 2025
Central reported a solid fiscal Q2 driven by operational execution and margin expansion despite a 7% sales decline to $834M caused by earlier preseason order timing, unseasonable weather (delaying the garden season), and the loss of two third‑party Garden product lines. Key positives: gross margin expanded 180 bps to 32.8%, non‑GAAP operating income held steady at $99M with operating margin up 80 bps, Pet delivered a record second‑quarter non‑GAAP operating income and e‑commerce penetration in Pet rose to 27%, and Wild Bird delivered record sales. The Cost & Simplicity program continues to drive productivity (inventory down $90M in the quarter) and logistics improvements (new DTC‑enabled and centralized distribution centers). Management reaffirmed fiscal 2025 non‑GAAP EPS guidance of $2.20 or higher while flagging heightened macro uncertainty from recent tariff actions, which may increase inflationary pressure (particularly in Pet durables/imports) and lead to a more promotional retail environment. Balance sheet and capital allocation highlights: $517M cash, total debt ~$1.2B, gross leverage ~2.9x and net leverage ~1.7x, continued share repurchases (~2.4M shares purchased year‑to‑date), and fiscal 2025 CapEx guidance of about $60M. M&A remains a priority (targeting high‑growth consumables), but deal flow is muted amid macro and tariff uncertainty. Management is focused on cost, supply‑chain flexibility, SKU rationalization and selective pricing to manage potential tariff impacts.
Sign In
Buy CENT